“One of our founding principles at AkrivisBio is to provide robust metabolic assays, which provide increased precision with a minimum amount of user effort as economically as possible,” said Nick Chacos, CEO of AkrivisBio. “Organizations are increasingly looking for reliable, reproducible, ready-to-use assays rather than developing them in-house so they can spend their time on the more important aspects of their research". Our assays are instrumental in biochemical research looking for solutions to cancer, diabetes, obesity, neurodegenerative disease, and other fields.
Based in the beautiful Bay area of Northern California, AkrivisBio is focused on improving the user experience with enzyme-based metabolic assays. Learn more at www.akrivisbio.com.
shyamali mandal
AkrivisBio Inc.
+1 309-857-5349
[email protected]
